Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism

Split-face investigation of the efficacy of applying Eflornithin cream twice daily for six months after a period with six laser treatments for hair removal.

Background: Unwanted facial hair growth is a serious problem for 5-15% of all women winch affects their quality of life. In Denmark patients are offered six laser treatments covered by the public health insurance. There is a lack of good follow-up treatments to this regime that can extent the efficacy of the laser treatment. Eflornithin cream is an approved treatment for reduction of facial hair growth which has proved to give an additional efficiency when used in combination with laser treatments.The efficacy when used after laser hair removal is not known. Aim: To investigate whether an extended efficacy of laser hair removal can be achieved with application of Eflornithin cream twice daily for six months after completion of laser treatments. Method: in a split-face trial to apply Eflornithin cream twice daily for six months. Outcome measures are investigator evaluation, blinded on-site evaluation, patient's assessment score and clinical photos.

Split face intervention with application of Eflornithine cream 11.5 w/w % versus no treatment for six months

Based on a four-point scale used on both sides of the face separately: no effect small effect (clearly visible hairs on evaluated side) large effect (minimal hair on evaluated side) significant effect (none or next to no hair on evaluated side)

Based on a four-point scale used on both sides of the face separately: no effect small effect (clearly visible hairs on evaluated side) large effect (minimal hair on evaluated side) significant effect (none or next to no hair on evaluated side)

Five common side-effects (acne, rash, erythema, changes in pigment, stinging or burning sensation) are evaluated based on a four-point scale: none mild moderate severe Other observed side effects will also be registered and rated

Five common side-effects (acne, rash, erythema, changes in pigment, stinging or burning sensation) are evaluated based on a four-point scale: none mild moderate severe Other observed side effects will also be registered and rated

Assessment of the patients impression of difference between two sides of the face on a four-point scale: No difference little difference large difference significant difference, complete or almost complete clearance of hair on treated side.

Inclusion Criteria: 18 years or older habile, understands Danish moderate to severe hirsutism prior to laser treatments succeeded minimum five laser treatments intact skin with no severe adverse events to laser treatments record of current medication and androgen hormone blood profile available Use of safe anti-conception (fertile women) Exclusion Criteria: Pregnant or lactating allergy toward the content of Eflornithin cream Concomitant use of immunosuppressive therapy Dementia, psychiatric disease, alcoholic